Forensic Sci Int 165 , 216224, (2007)
No returns allowed on 1/2 used product
First identified in human plasma in the 1970s, this small tripeptide glycyl-L-histidyl-L-lysine, bound to a copper ion has become one of the most extensively referenced compounds in dermal and wound-healing research literature, largely because its copper-binding structure gives it a distinct mechanism from most other peptide sciences on the market
Enhances Skin Barrier Function GHK-Cu reinforces the epidermal barrier, improving: Moisture retention Protection from environmental stressors Resilience against irritants This strengthens the skins natural defenses and reduces transepidermal water loss
Further focus was on the effects of NaBPC157 on the increased climbing behavior in mice
Recommended dosing: Subcutaneous: 200500 mcg per injection once or twice daily, rotating sites